Fresenius Medical Care AG & Co. KGaA (XETRA:FME) - Share price - Overview

Stock Report

Fresenius Medical Care AG & Co. KGaA FME

Last Price
87.78

Day Change
1.02|1.18%

As of 22/06/2018
17:35:10 CEST | EUR
Minimum 15 Minutes Delay.

Last Close86.76
Day Range86.40 - 87.78
Mkt Cap26.90Bil
52-Wk Range76.42 - 93.82
Yield %1.21
ISINDE0005785802
Volume390,332
P/E21.57
P/S1.57
P/CF13.65

Share Price

Financials
201520162017
More ...
Income Statement
Revenue15,309.2017,030.2917,783.57
Operating Income2,099.402,446.152,295.24
Net Income941.591,182.151,279.79
Basic EPS3.093.874.17
Avg. Diluted Shares Outstanding304306307
Balance Sheet
Current Assets6,388.516,954.406,374.31
Non Current Assets16,965.9518,655.4717,650.82
Total Assets23,354.4625,609.8724,025.13
Current Liabilities3,828.624,789.665,299.89
Total Liabilities---
Total Equity9,043.3710,277.379,820.10
Cash Flow
Operating Cash Flow1,792.782,034.692,191.81
Capital Expenditure-871.62-979.36-944.46
Free Cash Flow921.161,055.331,247.35

In millions, except "Basic EPS". Currency is EUR.

Company Profile

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. It develops and manufactures a full range of dialysis machines, systems, and disposable products. The company provides dialysis care and related services.

Sector

Healthcare

Industry

Medical Care

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

117,000
Key Stats
More ...
Price/Earning TTM21.32
Price/Book2.68
Price/Sales TTM1.55
Rev Growth (3 year avg)10.95
EPS Growth (3 year avg)-
Operating Margin % TTM12.91
Net Margin % TTM7.20
ROE TTM12.74
Debt/Equity0.59
Dividends
PreviousLatest
More ...
Declared Date28/03/1728/02/18
Ex-Div12/05/1718/05/18
Paid16/05/1723/05/18
Amnt0.961.06
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.